5301 Stevens Creek Blvd
+1 408 345 8886
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions
Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Our solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. The start-to-finish solution set means customers can get products to market faster. Customers trust us to help them test the purity of their therapeutics. Agilent also ensures that their instruments and processes conform to the highest compliance.
Within the pharmaceutical industry, an immense pressure exists to progress potential therapeutic candidates through the pipeline and to patients quicker than ever before. With pharmaceutical laboratories being on the front-line of drug development and quality control in manufacturing, the pressure for lab leaders to optimize the speed and efficiency of their operation is one crucial element of this bigger picture. When medicines have the potential to address critical unmet medical needs, the pharmaceutical laboratory’s need for speed becomes vital.
Laboratories are already employing strategies to be successful in this time-driven landscape, with many now turning to instrument providers to help them take this to the next level. Agilent Technologies is committed to supporting pharmaceutical laboratories in their mission to become more efficient by providing cutting-edge instruments, services and software that can help streamline laboratory workflows and aid laboratory leaders in meeting their organizational and personal goals… quickly!
US and Canada
Follow us for offers, events, applications and more
Accelerating the expansion of what we know about COVID-19 is critical to conquering the pandemic; the scientific and medical research communities stand united. Check out Agilent's COVID-19 Insights: https://t.co/tQPjgxDAAM pic.twitter.com/9Ywq4GmOGF— Agilent Technologies (@Agilent) March 3, 2021
In Agilent’s latest #podcast episode, we hear from Dr. Rod Chalk of the Centre for Medicines Discovery, Oxford, UK, as he discusses his research developing robust and reliable methods for analyzing SARS-CoV-2 spike proteins. Listen here: https://t.co/N39OwZlClc #coronavirus pic.twitter.com/tv9mMoGGa8— Agilent Technologies (@Agilent) March 3, 2021